Clinical significance and regulation of ERK5 expression and function in cancer

M Monti, J Celli, F Missale, F Cersosimo, M Russo… - Cancers, 2022 - mdpi.com
Simple Summary Alterations of the MEK5/ERK5 signaling pathway have been described in
several tumors, and emerging data are trying to explain the complexity of ERK5-related …

ERK5 signalling and resistance to ERK1/2 pathway therapeutics: The path less travelled?

SJ Cook, PA Lochhead - Frontiers in Cell and Developmental Biology, 2022 - frontiersin.org
The RAS-regulated RAF-MEK1/2-ERK1/2 signalling pathway is frequently de-regulated in
human cancer. Melanoma in particular exhibits a high incidence of activating BRAFV600E/K …

Modulation of ERK5 activity as a therapeutic anti-cancer strategy

DC Miller, SJ Harnor, MP Martin… - Journal of Medicinal …, 2023 - ACS Publications
The extracellular signal-regulated kinase 5 (ERK5) signaling pathway is one of four
conventional mitogen-activated protein (MAP) kinase pathways. Genetic perturbation of …

DDRugging glioblastoma: Understanding and targeting the DNA damage response to improve future therapies

O Rominiyi, SJ Collis - Molecular Oncology, 2022 - Wiley Online Library
Glioblastoma is the most frequently diagnosed type of primary brain tumour in adults. These
aggressive tumours are characterised by inherent treatment resistance and disease …

SMURF2 phosphorylation at Thr249 modifies glioma stemness and tumorigenicity by regulating TGF-β receptor stability

M Hiraiwa, K Fukasawa, T Iezaki, H Sabit… - Communications …, 2022 - nature.com
Glioma stem cells (GSCs) contribute to the pathogenesis of glioblastoma, the most
malignant form of glioma. The implication and underlying mechanisms of SMAD specific E3 …

High glucose increases DNA damage and elevates the expression of multiple DDR genes

MA Rahmoon, RA Elghaish, AA Ibrahim, Z Alaswad… - Genes, 2023 - mdpi.com
The DNA Damage Response (DDR) pathways sense DNA damage and coordinate robust
DNA repair and bypass mechanisms. A series of repair proteins are recruited depending on …

ERK5 suppression overcomes FAK inhibitor resistance in mutant KRAS-driven non-small cell lung cancer

C Pozzato, G Outeiro-Pinho, M Galiè… - EMBO Molecular …, 2024 - embopress.org
Mutated KRAS serves as the oncogenic driver in 30% of non-small cell lung cancers
(NSCLCs) and is associated with metastatic and therapy-resistant tumors. Focal Adhesion …

MEK5-ERK5 axis promotes self-renewal and tumorigenicity of glioma stem cells

K Fukasawa, J Lyu, T Kubo, Y Tanaka, A Suzuki… - Cancer Research …, 2023 - AACR
Glioma stem cells (GSC) promote the malignancy of glioblastoma (GBM), the most lethal
brain tumor. ERK5 belongs to the MAPK family. Here, we demonstrated that MAPK kinase 5 …

[HTML][HTML] Nanomedicines targeting the inflammasome as a promising therapeutic approach for cell senescence

S Chaturvedi, Z Naseem, SF El-Khamisy… - Seminars in Cancer …, 2022 - Elsevier
Technological advancements in the present era have enhanced drug discovery and
development. Nanomedicines are valuable pharmacotherapeutic tools against several …

Anticancer Activities of 9-chloro-6-(piperazin-1-yl)-11H-indeno [1, 2-c] quinolin-11-one (SJ10) in Glioblastoma Multiforme (GBM) Chemoradioresistant Cell Cycle …

N Mokgautsi, YC Kuo, SL Tang, FC Liu, SJ Chen… - Cancers, 2022 - mdpi.com
Simple Summary Glioblastoma multiforme (GBM) remains to be the most frequent malignant
tumor of the central nervous system (CNS), which accounts for approximately 54% of all …